WallStreetZenWallStreetZen

NASDAQ: MGTX
Meiragtx Holdings PLC Stock Forecast, Predictions & Price Target

Analyst price target for MGTX

Based on 1 analyst offering 12 month price targets for Meiragtx Holdings PLC.
Min Forecast
$11.00+123.12%
Avg Forecast
$11.00+123.12%
Max Forecast
$11.00+123.12%

Should I buy or sell MGTX stock?

Based on 1 analyst offering ratings for Meiragtx Holdings PLC.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MGTX stock forecasts and price targets.

MGTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is MGTX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is MGTX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MGTX revenue forecast

What is MGTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$67.4M
Avg 2 year Forecast
$269.6M
Avg 3 year Forecast
$334.0M

MGTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MGTX$4.93$11.00+123.12%Buy
AVIR$3.73N/AN/A
GUTS$6.55$18.00+174.81%Strong Buy
OCGN$1.25$6.00+380.00%Strong Buy
NAUT$2.49N/AN/A

Meiragtx Holdings Stock Forecast FAQ

Is Meiragtx Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MGTX) stock is to Buy MGTX stock.

Out of 1 analyst, 0 (0%) are recommending MGTX as a Strong Buy, 1 (100%) are recommending MGTX as a Buy, 0 (0%) are recommending MGTX as a Hold, 0 (0%) are recommending MGTX as a Sell, and 0 (0%) are recommending MGTX as a Strong Sell.

If you're new to stock investing, here's how to buy Meiragtx Holdings stock.

What is MGTX's revenue growth forecast for 2024-2026?

(NASDAQ: MGTX) Meiragtx Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Meiragtx Holdings's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast MGTX's revenue for 2024 to be $4,326,952,645, with the lowest MGTX revenue forecast at $4,326,952,645, and the highest MGTX revenue forecast at $4,326,952,645. On average, 1 Wall Street analysts forecast MGTX's revenue for 2025 to be $17,314,232,297, with the lowest MGTX revenue forecast at $17,314,232,297, and the highest MGTX revenue forecast at $17,314,232,297.

In 2026, MGTX is forecast to generate $21,451,102,131 in revenue, with the lowest revenue forecast at $21,451,102,131 and the highest revenue forecast at $21,451,102,131.

What is MGTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MGTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MGTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MGTX price target, the average MGTX price target is $11.00, with the highest MGTX stock price forecast at $11.00 and the lowest MGTX stock price forecast at $11.00.

The Wall Street analyst predicted that Meiragtx Holdings's share price could reach $11.00 by Mar 15, 2025. The average Meiragtx Holdings stock price prediction forecasts a potential upside of 123.12% from the current MGTX share price of $4.93.

What is MGTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MGTX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.